BMY is showing erie similarities of its last major cycle, and it appears massive downside is on the horizon. Decreasing RSI, strong support and resistance and the exact same chart pattern are more than enough to show BMY is likely headed down at least 20% over the next few months.
Sizable downside in the overall market over the next few months will likely add to the selling pressure. Price target is $32 by Q4 2019.
Sizable downside in the overall market over the next few months will likely add to the selling pressure. Price target is $32 by Q4 2019.